Recommendation based on Phase 3 Balance results, which showed a significant reduction of triglycerides and substantial reduction of acute pancreatitis events with TRYNGOLZA European Commission decision expected by Q4 2025 STOCKHOLM, July 25, 2025 /PRNewswire/ -- Sobi® (STO: SOBI) and...
Hence then, the article about tryngolza olezarsen recommended for eu approval by chmp for familial chylomicronemia syndrome fcs was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( TRYNGOLZA® (olezarsen) recommended for EU approval by CHMP for familial chylomicronemia syndrome (FCS) )
Also on site :
- Nazanin Zaghari-Ratcliffe joins 100 Iranians urging UK not to get drawn further into Iran war
- Huawei и China Telecom получили награду GSMA GLOMO за вклад в улучшение жизни детей и молодежи
- Global Times: A stable China is fertile ground for foreign businesses to develop